Joanne Wendy Kim

CIK: 0001771317

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BIVI

BIOVIE INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

BIVI
BIOVIE INC.
Aug 28, 2026
Purchase(P)
Direct
2.5K shares at avg. $2.18$5K
BIVI
BIOVIE INC.
Jan 5, 2026
Award(A)
Stock Option (right to buy)
Direct
110.1K shares-
BIVI
BIOVIE INC.
Dec 20, 2024
Award(A)
Stock Option (right to buy)
Direct
14.4K shares-

		Type	Shares	Price		Ownership
Aug 28, 2026	BIVI BIOVIE INC.	Purchase(P)	2,500	$2.18	$5,450	Direct
Jan 5, 2026	BIVI BIOVIE INC.	Award(A) Stock Option (right to buy)	110,100	-	-	Direct
Dec 20, 2024	BIVI BIOVIE INC.	Award(A) Stock Option (right to buy)	14,417	-	-	Direct

1-3 of 3 transactions

About KIM JOANNE WENDY

KIM JOANNE WENDY (SEC CIK 0001771317) files insider reports with the SEC as Chief Financial Officer of BIOVIE INC. (BIVI).

Signal8 holds 3 ownership filings by KIM JOANNE WENDY, all Form 4s, filed between Jan 7, 2025 and Aug 28, 2026. Those filings report 3 transactions, from Dec 20, 2024 to Aug 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on KIM JOANNE WENDY's filings is in CARSON CITY, NV.

Recent filings by KIM JOANNE WENDY

Aug 28, 2026: Open-market purchase of BIVI shares (Form 4, code P).
Jan 5, 2026: Grant or award of BIVI derivative securities (Form 4, code A).
Dec 20, 2024: Grant or award of BIVI derivative securities (Form 4, code A).

Other insiders filing for BIOVIE INC. (BIVI)

Palumbo Joseph M, Chief Medical Officer
Chappell Amy Suzon, Director
DO CUONG V, President & CEO
ROGICH SIGMUND, Director
Sherman Michael Edward, Director
Farag Kameel D., Director

How to read Form 4 transaction codes